1. P528 Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multi-centre, prospective, observational cohort study. (25th January 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP80 Oral curcumin is not more effective than placebo to prevent endoscopic postoperative recurrence in patients with Crohn's disease treated with concomitant thiopurines: the POPCUR trial. (25th January 2019) Authors: Buisson, A; Laharie, D; Nancey, S; Hébuterne, X; Roblin, X; Nachury, M; Peyrin-Biroulet, L; Fumery, M; Goutorbe, F; Coban, D; Allimant, C; Reymond, M; Vazeille, E; Pereira, B; Goutte, M; Bommelaer, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S078 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP78 Efficacy of vedolizumab in perianal Crohn's disease: the BioLAP multi-centre observational study. (25th January 2019) Authors: Biron, C; Seksik, P; Nachury, M; Nancey, S; Bouhnik, Y; Serrero, M; Armengol-Debeir, L; Buisson, A; Tran Minh, M-L; Zallot, C; Fumery, M; Bouguen, G; Abitbol, V; Viennot, S; Chanteloup, E; Rajca, S; Dib, N; Peyrin-Biroulet, L; Vuitton, L Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP25 Targeting endoscopic outcomes through combined pharmacokinetic and pharmacodynamic monitoring of infliximab therapy in patients with Crohn's disease. (25th January 2019) Authors: Dreesen, E; Baert, F; Laharie, D; Bossuyt, P; Bouhnik, Y; Buisson, A; Lambrecht, G; Louis, E; Oldenburg, B; Pariente, B; Pierik, M; van der Woude, C J; D'Haens, G; Vermeire, S; Gils, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P226 Systematic review with meta-analysis of individual data: impact of cut-off values on the performance of faecal calprotectin to detect endoscopic recurrence after intestinal resection in patients with Crohn's disease. (25th January 2019) Authors: Kirchgesner, J; Boschetti, G; Buisson, A; Yamamoto, T; Domenech, E; Nancey, S; Peyrin-Biroulet, L; Uzzan, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P163 Transmural healing assessed using MRI scores is associated with better outcomes and is a potential therapeutic target in patients with Crohn's disease. (25th January 2019) Authors: Buisson, A; Vignette, J; Allimant, C; Reymond, M; Pereira, B; Bommelaer, G; Hordonneau, C Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study. (22nd February 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DOP74 Efficacy of ustekinumab in perianal Crohn's disease: the BioLAP multi-centre observational study. (25th January 2019) Authors: Biron, C; Seksik, P; Nachury, M; Bouhnik, Y; Amiot, A; Viennot, S; Serrero, M; Fumery, M; Allez, M; Siproudhis, L; Buisson, A; Pineton de Chambrun, G; Abitbol, V; Nancey, S; Caillo, L; Plastaras, L; Armengol-Debeir, L; Chanteloup, E; Simon, M; Dib, N Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P711 The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study. (25th January 2019) Authors: Amiot, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Pariente, B; Roblin, X; Buisson, A; Stefanescu, C; Trang-Poisson, C; Altwegg, R; Marteau, P; Vaysse, T; Bourrier, A; Nancey, S; Laharie, D; Allez, M; Savoye, G; Moreau, J; Vuitton, L; Viennot, S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P413 A simple scoring tool predicts exposure–response relationship, onset of action, response to interval shortening, and surgical risk with vedolizumab therapy for Crohn's disease. (25th January 2019) Authors: Dulai, P S; Amiot, A; Peyrin-Biroulet, L; Singh, S; Serrero, M; Jairath, V; Filippi, J; Pariente, B; Loftus Jr, E V; Roblin, X; Kane, S; Buisson, A; Siegel, C A; Bouhnik, Y; Sandborn, W J; Lasch, K; Rosario, M; Feagan, B G; Bojic, D; Trang-Poisson, C Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗